首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Tumori

缩写:

ISSN:0300-8916

e-ISSN:2038-2529

IF/分区:2.0/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引1811条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Alessandro Leonetti,Giuseppe Maglietta,Marianna Peroni et al. Alessandro Leonetti et al.
IntroductionChemo-immunotherapy (CT-IT) currently represents the standard therapy for both non-small (NSCLC) and small cell lung cancer (SCLC). However, the differential impact of platinum compounds on immunotherapy outcomes remains to be d...
Carla Bettini,Andrea Carlini,Laura Fabbri et al. Carla Bettini et al.
Purpose: This retrospective single-center observational study aimed to describe our experience of admitting patients based on palliative care needs rather than discontinuation of anticancer treatment. ...
Costantino Putzu,Federico Mastroleo,Mattia Zaffaroni et al. Costantino Putzu et al.
Background and purpose: Re-irradiation is increasingly recognized as a viable and safe treatment option for prostate cancer (PCa) local recurrence. The aim of this study is to present the safety profile, feasibility, and ...
Valentina Di Ruscio,Ida Russo,Angela Di Giannatale et al. Valentina Di Ruscio et al.
Ewing sarcoma (ES) occurs in the head and neck (HN) region in fewer than 10% of cases, presenting distinct therapeutic challenges.We retrospectively reviewed all ES cases diagnosed at our institution from 2000 to 2022.Of 131 patients, 10 (7...
Giulia Fontana,Sithin Thulasi Seetha,Sara Lillo et al. Giulia Fontana et al.
Objective: While artificial intelligence (AI) is known to benefit radiotherapy (RT), its applications in carbon ion RT (CIRT) is yet to be surveyed. This scoping review aims to examine the current landscape of AI in CIRT ...
Amit Kumar,Nisha Manav,Mayank Singh et al. Amit Kumar et al.
Intratumor heterogeneity (ITH) describes the diversity of cancer cells within a single tumor. This heterogeneity includes differences in the cells' phenotypes, genotypes, and functions. As a result, cancer cells can vary in their morphology...
Raffaela D G Sartori,Davide Dalu,Davide De Francesco et al. Raffaela D G Sartori et al.
Introduction: The old oncology approach, which considered the clinical and performance status as the most relevant diseases course and well-being indexes, has been recently replaced by a care system also focusing on a per...
Zhengyi Wang,Xiaoying Wu Zhengyi Wang
Preclinical immunotherapy research relies heavily on animal tumor models, which can be broadly classified into four categories: genetically engineered, carcinogen-induced, spontaneous, and humanized transplantation platforms. While these sy...
Alessandro Leonetti,Vanessa Callegari,Fabiana Perrone et al. Alessandro Leonetti et al.
IntroductionChemo-immunotherapy is the standard frontline treatment of advanced non-squamous non-small cell lung cancer (nsq-NSCLC). Among oncogenic drivers, KRAS mutation accounts for approximately 25% of lung adenocarcinomas, with p.G12C ...
Wen Tang,Min Zhao,Juan He et al. Wen Tang et al.
Purpose: Natural killer/T-cell lymphoma (NKTCL) is an aggressive lymphoma. Glutathione peroxidase 1 (GPX1) is a prevalent isoform with reported roles in various tumors and prognostic implications. However, GPX1's role in ...